Back to News
Market Impact: 0.25

RBC Capital downgrades GitLab stock rating on near-term headwinds

GTLB
Analyst InsightsCompany FundamentalsCorporate Guidance & OutlookArtificial IntelligenceTechnology & InnovationProduct LaunchesManagement & Governance
RBC Capital downgrades GitLab stock rating on near-term headwinds

RBC Capital downgraded GitLab to Sector Perform from Outperform and cut its price target to $25 from $33, citing short-term headwinds including tougher Premium pricing comps, SMB exposure, and first-order sales transition risk. The firm sees Duo Agent Platform as a medium-term catalyst but not a near-term driver, while still describing GitLab as an attractive long-term DevSecOps and takeover candidate. GitLab also released version 18.11 with AI-powered security features, expanded its Google Cloud AI collaboration, and announced a board committee change.

Analysis

The key issue is not the rating cut itself but the setup for multiple compression in a market that still wants to value GTLB on forward ARR durability. When a software name has already been derated this hard, incremental bad news matters less than the absence of a re-acceleration path; that shifts the stock into a “prove it” regime where every quarter of mediocre seat growth can anchor the shares in a low-trend range. The market is also likely underappreciating how layoffs and procurement caution hit GitLab twice: fewer users today, and slower net-expansion later because administrative consolidation tends to reduce tool sprawl. The medium-term AI catalyst is real, but it is probably being misread as a near-term revenue bridge. Agentic features usually improve retention before they expand spend, so the first order effect is defensive rather than expansive; that means the stock can look product-strong while still failing the earnings math. In other words, AI may raise the strategic value of the platform without fixing the near-term valuation problem, which is why the takeover angle remains the cleanest bull case: strategic value can rise even if public-market sentiment stays muted. The contrarian risk is that the downside may already be priced if profitability arrives on schedule and management avoids another pricing misstep. If margins inflect while churn stays controlled, the short thesis loses its most important lever because the company would no longer be “growth at any cost” but a niche platform with operating leverage. The key timing window is the next 1-2 earnings prints: if billings and seat trends stabilize, the stock can rerate quickly; if not, expect a multi-month range with rallies sold into.